-
Prednisone: Reliable Cell Assay Workflows
2026-08-24
This scenario-driven guide shows how Prednisone, SKU B2148, can help researchers control solvent effects, interpret lymphocyte viability and apoptosis data, and build reproducible corticosteroid assays. It combines mechanism-based experimental design with practical handling, storage, and vendor-selection guidance.
-
Sulfo-Cy3 NHS Ester for Vascular Assays
2026-08-24
Sulfo-Cy3 NHS Ester combines water compatibility with amine-selective labeling, making it useful for tracking vascular proteins, uptake pathways, and endothelial-cell remodeling without relying on organic cosolvents. This practical guide connects the dye to the AIBP-LRP2–HDL–CXCR4 biology of collateral circulation and provides starting conditions for reproducible conjugation, imaging, and troubleshooting.
-
Amorolfine Hydrochloride and Fungal Cell Integrity
2026-08-23
Amorolfine Hydrochloride is an antifungal reagent for studying membrane-synthesis phenotypes through a ploidy-aware assay framework. This article connects product handling, fungal cell membrane disruption, and the latest yeast evidence to improve mechanistic and antifungal resistance studies.
-
IGF2BP3–RCC2 Axis in Acute Myeloid Leukemia
2026-08-22
The reference study identifies the m6A reader IGF2BP3 as an AML-associated survival factor that promotes leukemic progression by stabilizing RCC2 mRNA. Its combination of patient-sample analysis, cellular perturbation, RNA-binding experiments, and in vivo validation connects an epitranscriptomic regulator to a defined post-transcriptional mechanism with implications for cancer research.
-
Actinomycin D Workflows for RNA Stability Research
2026-08-22
Actinomycin D enables controlled transcription shutdown for mRNA decay, apoptosis induction, and transcriptional stress studies. This workflow translates the FTO–FOXO1 findings in adipose-derived stem cells into practical ActD assay designs while emphasizing dose control, RNA normalization, and cytotoxicity-aware interpretation.
-
HyperScript III RT SuperMix for qPCR
2026-08-21
Learn how HyperScript™ III RT SuperMix for qPCR (with gDNA wiper), SKU K1585, can strengthen gene-expression readouts that support cell viability, proliferation, and cytotoxicity studies. This scenario-based guide covers genomic DNA contamination removal, difficult RNA templates, protocol design, interpretation, and practical reagent selection.
-
Tigecycline: From Mechanism to MDR Translation
2026-08-20
Tigecycline offers translational researchers a mechanistically defined way to study protein-translation inhibition in resistant bacterial models. This article connects its glycylcycline pharmacology with carbapenemase-gene transmission, MRSA and GISA models, experimental design, and clinically relevant decision-making.
-
Aztreonam Workflows for Gram-Negative Research
2026-08-20
Build reproducible Aztreonam assays for Gram-negative susceptibility, resistance profiling, and host-drug interaction studies. This workflow-focused guide connects concentration control and assay design with comparative evidence from resistant Pseudomonas aeruginosa and Acinetobacter research.
-
Cycloastragenol Protects Against Glucocorticoid Bone Loss
2026-08-19
This in vivo study shows that cycloastragenol reduces femoral-head necrosis and trabecular bone loss in a methylprednisolone-induced rat model by suppressing osteoclast activity. Its integrated use of micro-CT, angiography, histology, gene expression, and protein analysis supports osteoclast inhibition as a potential hip-preservation strategy, while leaving important translational questions unresolved.
-
Octenidine (dihydrochloride) in Cell Assays
2026-08-19
A scenario-based guide to using Octenidine (dihydrochloride), SKU C6432, in antimicrobial, cell-viability, and cytotoxicity workflows. It connects membrane-disruption biology with practical controls, stock preparation, data interpretation, and evidence-based product selection.
-
Thiamet G: From O-GlcNAc to Translational Insight
2026-08-18
Thiamet G provides a pharmacological route to interrogate O-GlcNAcase biology across tau, leukemia, and bone models. This thought-leadership article connects target engagement with Wnt-driven glycolysis and osteogenesis, while distinguishing established evidence from translational hypotheses.
-
Trilaurin Workflows for Biocatalysis and Drug Delivery
2026-08-18
Trilaurin, also known as Glycerol Tridodecanoate, is a defined C12 triglyceride that supports both enzyme-cascade synthesis and lipid-based delivery research. This practical guide covers solvent preparation, assay design, particle formulation, evidence-backed benchmarks, and troubleshooting for reproducible workflows.
-
From Viability Signal to Senolytic Mechanism
2026-08-17
A translational framework for using Cell Counting Kit-8 Plus to connect WST-8 viability signals with senolytic mechanism, experimental validation, and realistic drug-development decisions.
-
PBA-Modified PAD4 Inhibitors Block Tumor NETs
2026-08-17
The reference study developed phenylboronic acid–modified PAD4 inhibitors to improve tumor targeting while suppressing the PAD4–H3cit–NET pathway. Compound 5i showed selective uptake behavior, reduced tumor-associated NET formation, inhibited primary tumor growth and lung metastasis, and produced a favorable safety profile in mouse models.
-
MK-1775: Practical Wee1 Kinase Inhibitor Workflows
2026-08-16
Learn how to use MK-1775 to interrogate Wee1-dependent checkpoint control, distinguish growth arrest from cell death, and test chemotherapy sensitization in p53-deficient models. This workflow emphasizes mechanism-aligned controls, time-resolved readouts, and troubleshooting for interpretable combination data.